Charles River Laboratories | CRL - Beneficio Operativo

Precio De Mercado
166.97
Cambio Diario
3.13 1.91%
Mensual
-3.21%
Anual
42.84%
Q2 Expectativa
166.17




Beneficio Operativo Cambio Fecha
Agilent USD 353M 90M 2025-12
Align Technology USD 178.05M 46.66M 2026-03
Bio-Rad Laboratories USD 53.9M 10M 2025-12
Bruker USD 76.3M 7.6M 2025-12
Cardinal Health USD 861M 98M 2026-03
Charles River Laboratories USD 75.82M 57.98M 2025-12
Cigna USD 2.76B 204M 2026-03
Concord Medical Services Hldg CNY -144.65M 69.38M 2025-06
CVS Health USD 2.11B 836M 2025-12
Danaher USD 1.34B 158M 2026-03
Dentsply International USD 538M 26M 2025-12
Elevance Health USD -5.81B 6.39B 2026-03
Galapagos EUR 780.56M 822.23M 2025-12
Humana USD 1.75B 2.56B 2026-03
Illumina USD 239M 17M 2026-03
Incyte USD 383.88M 47.43M 2025-12
Intrexon USD -60.84M 26.62M 2024-06
IQVIA Holdings USD 2.68B 2.1B 2025-12
Laboratory Of America USD 410.1M 28.1M 2026-03
Lonza CHF 673M 243M 2025-06
McKesson USD 1.66B 159M 2025-12
Merck EUR 474M 738M 2025-12
Mettler Toledo International USD 351.93M 57.73M 2025-12
Novartis USD 4.24B 171M 2026-03
Pfizer USD 4.65B 3.99B 2025-12
Quest Diagnostics USD 399M 13M 2026-03
Revvity USD 145.83M 47.49M 2025-12
Thermo Fisher Scientific USD 1.91B 389M 2026-03
United Therapeutics USD -14.6M 403.9M 2025-12
UnitedHealth USD 9.04B 5.78B 2026-03
Veradigm USD -45.47M 70.47M 2022-12
Waters USD 270.52M 78.4M 2025-12
West Pharmaceutical Services USD 177.1M 14.6M 2026-03